Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes
Chrysavgi Lalayanni(G. Papanikolaou General Hospital), Ioanna Sakellari(G. Papanikolaou General Hospital), Μαρία Παπαθανασίου(Goethe University Frankfurt), Anastasia Athanasiadou, Antonia Syrigou(G. Papanikolaou General Hospital), Ioannis Batsis(G. Papanikolaou General Hospital), Charikleia Kelaïdi(Hôpital Avicenne), Sophia Polychronopoulou(University of California, Berkeley), Anna Vardi(G. Papanikolaou General Hospital), Christos Demosthenous(G. Papanikolaou General Hospital), Michail Iskas(G. Papanikolaou General Hospital), Apostolia Papalexandri(G. Papanikolaou General Hospital)
Cited by 9
Related Papers
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience
|Blood|2007|332
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
|Nature Medicine|2021|170
Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group Experience
|Journal of Clinical Oncology|2009|120